A retrospective non-interventional study to evaluate the use of Seroquel extended release (XR) and Immediate Release (IR) in the clinical practice of inpatients with schizophrenia - SPIN
Study identifier:NIS-NSE-SER-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A retrospective, non-interventional study to evaluate the use of Seroquel XR and Seroquel IR in the clinical practice of inpatients with schizophrenia
Medical condition
schizophrenia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
300
Study type
Observational
Age
18 Years - 65 Years
Date
Study Start Date: 01 Oct 2010
Primary Completion Date: 01 Dec 2010
Study Completion Date: 01 Dec 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Patients with a diagnosis of schizophrenia who have been hospitalized and received at least one dose of Seroquel XR or Seroquel IR during the study period (1st of July 2009 – 30th of September 2010). | - |
Contacts
Investigators
Principal Investigator
Dr Eva Dencker Vansvik
AstraZeneca
